MAXONA Pharmaceuticals logo — Maxona pharmaceuticals is committed to leveraging an ex-u

MAXONA Pharmaceuticals

Maxona pharmaceuticals is committed to leveraging an ex-u

Founded 2016 United States Malvern, United States 9 employees Unknown Total: $5.60M Biotechnology, Health Care +3

General Information

Company Name MAXONA Pharmaceuticals
Founded Year 2016
Location United States Malvern, United States +1
Employees 9
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Unknown
Social

Get notified when MAXONA Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MAXONA Pharmaceuticals

MAXONA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company leveraging innovation to develop the next generation of therapies to help patients maximize life. MAXONA's initial focus is on addressing the urgent need for new effective therapies that treat acute and chronic pain, without the side effects and addiction risks associated with NSAIDS and opioids. MAXONA's lead compound, MAX-001 is a non-opioid, non-NSAID oral therapy with a novel mechanism of action that is initially being developed in the U.S. to treat acute and chronic pain. MAX-001 is a patent protected optimized formulation of nefopam. which is widely used and extensively studied outside the U.S. to treat acute and chronic pain. MAXONA has assembled a highly experienced and well recognized leadership team with a proven record of successfully developing and commercializing effective therapeutics. With deep experience in all areas of clinical development and commercialization, the leadership team is well-equipped to realize MAXONA's vision to help patients maximize life.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• - 01 May 2021

MAXONA Pharmaceuticals Alternatives & Competitors

MAXONA Pharmaceuticals vs
Neumentum, Inc.
Neumentum, Inc. United States

Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceut...

Series Unknown
6 employees
Biotechnology, Health Care
MAXONA Pharmaceuticals vs
Lucid Lane Inc.
Lucid Lane Inc. United States

Lucid Lane empowers people living with substance use and pain to live a better and healthier life.

Series A
23 employees
MAXONA Pharmaceuticals vs
Rejuvinix
Rejuvinix United States

Groundbreaking, Non-Surgical Treatments to Help Eliminate Knee and Joint Pain

11 employees
Health Care, Health and Wellness

FAQ About MAXONA Pharmaceuticals

Maxona pharmaceuticals is committed to leveraging an ex-u
MAXONA Pharmaceuticals was founded in 2016.
MAXONA Pharmaceuticals is headquartered in Malvern, United States.
MAXONA Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences, Pharmaceutical.
MAXONA Pharmaceuticals has approximately 9 employees.
MAXONA Pharmaceuticals has completed 1 funding round, raising a total of $5.60M. The latest funding stage is Unknown.
Top alternatives and competitors to MAXONA Pharmaceuticals include Neumentum, Inc., Lucid Lane Inc., Rejuvinix, Chicago Sports and Spine, SEVA Med Care. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MAXONA Pharmaceuticals and Neumentum, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MAXONA Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy